1-5 of 5
Michael V. Knopp
Close
Sort by
Journal Articles

Local Review Versus (vs) Central Review of Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) in Diffuse Large B-Cell Lymphoma (DLBCL): Results from the CALGB 50303 Trial [Alliance]

Amy S. Ruppert, PhD, Levi D. Pederson, MS, Michael V. Knopp, MD PhD, David Poon, BS, Jun Zhang, PhD, Brad S. Kahl, MD, Jonathan W. Friedberg, MD MSSc, Lawrence H. Schwartz, MD, Wyndham H. Wilson, MD PhD, John P. Leonard, MD, Nancy L. Bartlett, MD, Heiko Schöder, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 50.
https://doi.org/10.1182/blood-2020-139979
Published: 2020
Journal Articles

Prognostic value of interim FDG-PET in diffuse large cell lymphoma: results from the CALGB 50303 Clinical Trial

Clinical Trials & Observations
Heiko Schöder, Mei-Yin C. Polley, Michael V. Knopp, Nathan Hall, Lale Kostakoglu, Jun Zhang, Howard R. Higley, Gary Kelloff, Heshan Liu, Andrew D. Zelenetz, Bruce D. Cheson, Nina Wagner-Johnston, Brad S. Kahl, Jonathan W. Friedberg, Eric D. Hsi, John P. Leonard, Lawrence H. Schwartz, Wyndham H. Wilson, Nancy L. Bartlett
Journal: Blood
Blood (2020) 135 (25): 2224–2234.
https://doi.org/10.1182/blood.2019003277
Published: 2020
Includes: Supplemental data
Journal Articles

The Optimal Timing of Interim 18F-FDG PET in Diffuse Large B-Cell Lymphoma: An Individual Patient Data Meta-Analysis By the Petra Consortium

Jakoba J Eertink, MSc, Coreline N Burggraaff, MD, Martijn W Heymans, PhD, Sally F Barrington, Prof, MD PhD, George Mikhaeel, Prof, MD PhD, Ulrich Dührsen, Prof, MD PhD, Andreas Hüttmann, MD, Luca Ceriani, MD, Emanuele Zucca, MD, Robert Carr, MD, Tamás Györke, MD PhD, Stefano Fanti, Prof, MD PhD, Howard R Higley, PhD, Michael V Knopp, MD PhD, Heiko Schöder, MD, Annika Loft, MD PhD, Martin Hutchings, MD PhD, Lale Kostakoglu, Prof, MD PhD, Pieternella Lugtenburg, MD PhD, Sanne E Wiegers, MSc, Simone Pieplenbosch, MSc, Ronald Boellaard, MSc, PhD, Otto S Hoekstra, MD PhD, Josée M Zijlstra, MD PhD, Henrica C.W. de Vet, Prof, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 487.
https://doi.org/10.1182/blood-2019-122298
Published: 2019
Journal Articles

Five-year follow-up of SWOG S0816: limitations and values of a PET-adapted approach with stage III/IV Hodgkin lymphoma

Deborah M. Stephens, Hongli Li, Heiko Schöder, David J. Straus, Craig H. Moskowitz, Michael LeBlanc, Lisa M. Rimsza, Nancy L. Bartlett, Andrew M. Evens, Ann S. LaCasce, Paul M. Barr, Michael V. Knopp, Eric D. Hsi, John P. Leonard, Brad S. Kahl, Sonali M. Smith, Jonathan W. Friedberg
Journal: Blood
Blood (2019) 134 (15): 1238–1246.
https://doi.org/10.1182/blood.2019000719
Published: 2019
Includes: Supplemental data
Journal Articles

Long-Term Follow-up of SWOG S0816: Response-Adapted Therapy for Stage III/IV Hodgkin Lymphoma Demonstrates Limitations of PET-Adapted Approach

Deborah M. Stephens, Hongli Li, MS, Heiko Schoder, MD, David J. Straus, MD, Craig H. Moskowitz, MD, Michael L. Leblanc, PhD, Lisa M. Rimsza, MD, Nancy L. Bartlett, MD, Andrew M. Evens, DO, MSc, Ann S. LaCasce, MD MSc, Paul Barr, MD, Michael V. Knopp, Eric D. Hsi, MD, John P. Leonard, MD, Brad S Kahl, MD, Sonali M. Smith, MD, Jonathan W. Friedberg, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 929.
https://doi.org/10.1182/blood-2018-99-113034
Published: 2018